Ilja Spellmann

37 papers receiving 1.6k citations

Ilja Spellmann's Hit Papers

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine 2006 · 630 citations
6300+6+13Years since publication200400600

Peers

Ilja Spellmann
Comparison fields: 5 of 100
  • Biological Psychiatry 657
  • Behavioral Neuroscience 398
  • Psychiatry and Mental health 506
  • Neurology 146
  • Cellular and Molecular Neuroscience 171
Replace Anja Cerovecki with:
Anja Cerovecki Germany
Nico J.M. van Beveren Netherlands
Karina S. MacDowell Spain
Ian Schapkaitz Australia
Alain Gendron Canada
Tae‐Youn Jun South Korea
Lian Yuan Cao China
Miquel Bioque Spain
Gohei Yagi Japan
H-J Möller Germany
Ilja Spellmann relative to Anja Cerovecki Germany Anja Cerovecki's profile →
Citations per field
00.5×
Anja Cerovecki · 1×
Citations per year

Countries citing papers authored by Ilja Spellmann

Since Specialization
Citations

This map shows the geographic impact of Ilja Spellmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilja Spellmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilja Spellmann more than expected).

Fields of papers citing papers by Ilja Spellmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilja Spellmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilja Spellmann. The network helps show where Ilja Spellmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Ilja Spellmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ilja Spellmann Line = papers co-authored together Ilja Spellmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
Hit paper breakdown →
2006630
2 2004107
3 2011104
4 200563
5 200761
6 200656
7 200551
8 201050
9 200648
10 200744
11 200742
12 201040
13 201235
14 200934
15 201734
16 200933
17 200830
18 200829
19 201428
20 200625

About Ilja Spellmann

Ilja Spellmann is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Pharmacology, Cellular and Molecular Neuroscience and Cognitive Neuroscience, having authored 37 papers that have together received 1.7k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (18 papers), Bipolar Disorder and Treatment (6 papers), Tryptophan and brain disorders (6 papers), Treatment of Major Depression (5 papers), Genetics and Neurodevelopmental Disorders (4 papers), Obsessive-Compulsive Spectrum Disorders (3 papers), Autism Spectrum Disorder Research (3 papers) and Genetic Associations and Epidemiology (3 papers). The work is most often cited by research in Biological Psychiatry (657 citations), Behavioral Neuroscience (398 citations), Psychiatry and Mental health (506 citations), Neurology (146 citations) and Cellular and Molecular Neuroscience (171 citations). Ilja Spellmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Michael Riedel, Norbert Müller, Sandra Dehning, Markus Schwarz, Anja Cerovecki, Volker Arolt, Nikolaus Kleindienst, Richard Musil, Katja Maino and Guenter Hetzel. Their work appears in journals such as European Archives of Psychiatry and Clinical Neuroscience, Journal of Psychiatric Research, European Neuropsychopharmacology, Pharmacopsychiatry and Psychiatry Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact